ReviewImmunological reviews2026
Diversity, Equality, and Inclusion in the naïve T Cell Receptor Repertoire.
Review in Immunological reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The naïve T cell receptor (TCR) repertoire forms the immunological background from which adaptive cellular immune responses emerge. We examine the fundamental properties of the human naïve TCR repertoire through the perspective of Diversity, Equality, and Inclusion. We first consider the richness of the repertoire. A combination of experimental and computational approaches has been used to estimate that the human repertoire contains at least 100 million distinct naïve clonotypes. This estimate suggests an average size of each clonotype of 1000 T cells. However, evidence from both mathematical modeling and large-scale single-cell sequencing indicates that clonotype family sizes are very unequal, with a small subset of naïve TCRs present at substantially higher frequencies. Somatic recombination itself does not contribute significantly to this inequality, as the probability of generating an identical clonotype multiple times in an individual is very small. Instead, clonotype size is likely to be largely driven by thymic or post-thymic expansion, but the mechanisms driving heterogeneity remain poorly understood. Finally, despite clonal deletion being a cornerstone of immunological dogma, experimental evidence for functional "holes" in the naïve repertoire caused by negative thymic selection is surprisingly limited. Alternative tolerance mechanisms, including regulatory T cells and T cell quorum sensing, are likely to play important roles. This review highlights the need for further research to identify the mechanisms that shape the frequency distribution of naïve TCR clone sizes and to define its impact on primary immune responses. Further research is also needed to understand the role of quorum sensing in maintaining T cell tolerance, while avoiding potential vulnerabilities arising from extensive 'holes' in the TCR repertoire.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.